Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models.

Perera, Yasser; Toro, Neylen Del; Gorovaya, Larisa; Fernandez-DE-Cossio, Jorge; Farina, Hernan G; Perea, Silvio E

Perera, Yasser; Toro, Neylen Del; Gorovaya, Larisa; Fernandez-DE-Cossio, Jorge; Farina, Hernan G; Perea, Silvio E.

Afiliação

Perera Y; Laboratory of Molecular Oncology, Division of Pharmaceuticals, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba.
Toro ND; Laboratory of Molecular Oncology, Division of Pharmaceuticals, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba.
Gorovaya L; Animal Facility Unit, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba.
Fernandez-DE-Cossio J; Department of Bioinformatics, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba.
Farina HG; Laboratory of Molecular Oncology, Quilmes National University, Bernal, Buenos Aires B1876BXD, Argentina.
Perea SE; Laboratory of Molecular Oncology, Division of Pharmaceuticals, Center for Genetic Engineering and Biotechnology (CIGB), Havana 10600, Cuba.

Mol Clin Oncol ; 2(6): 935-944, 2014 Nov.

Article em En | MEDLINE | ID: mdl-25279177

Palavras-chave

CIGB-300; casein kinase 2; chemotherapy; drug combination; synergism

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Cuba

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google